Added to YB: 2025-05-09
Pitch date: 2025-05-08
PLRX [neutral]
Pliant Therapeutics, Inc.
-15.17%
current return
Author Info
No bio for this author
Company Info
Pliant Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing integrin-based therapeutics for the treatment of solid tumors.
Market Cap
$74.3M
Pitch Price
$1.45
Price Target
N/A
Dividend
N/A
EV/EBITDA
0.66
P/E
-0.65
EV/Sales
N/A
Sector
Pharmaceuticals
Category
special_situation
Special Situations Round-Up 19/25 - Pliant Therapeutics, Inc.
PLRX (quick overview): Trading at 0.33x NCAV, cutting 45% of workforce while awaiting lead study data (expected this quarter) after trial closed for safety concerns. Strategic decision coming post-results - may salvage lead candidate, pivot to early pipeline, or initiate full strategic review.
Read full article (1 min)